(Q28166614)

English

Risk of bleeding complications with antiplatelet agents: meta-analysis of 338,191 patients enrolled in 50 randomized controlled trials

scientific article (publication date: 2004)

In more languages

edit

Statements

0 references

1 reference

Risk of bleeding complications with antiplatelet agents: meta-analysis of 338,191 patients enrolled in 50 randomized controlled trials (English)

0 references

0 references

0 references

Victor L Serebruany

1

0 references

Alex I Malinin

series ordinal

2

0 references

Roswith M Eisert

series ordinal

3

0 references

David C Sane

series ordinal

4

0 references

language of work or name

English

0 references

publication date

January 2004

0 references

published in

American Journal of Hematology

0 references

volume

75

0 references

issue

1

0 references

page(s)

40-7

0 references

cites work

Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction. ReoPro and Primary PTCA Organization and Randomized Trial (RAPPORT) Investigators.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FAJH.10451

retrieved

21 January 2018

Mitral valve rupture following percutaneous mitral commissurotomy: existence of predictive factors.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FAJH.10451

retrieved

21 January 2018

Randomized trial of aspirin, sibrafiban, or both for secondary prevention after acute coronary syndromes

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FAJH.10451

retrieved

21 January 2018

Oral glycoprotein IIb/IIIa inhibition with orbofiban in patients with unstable coronary syndromes (OPUS-TIMI 16) trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FAJH.10451

retrieved

21 January 2018

Randomized evaluation of anticoagulation versus antiplatelet therapy after coronary stent implantation in high-risk patients: the multicenter aspirin and ticlopidine trial after intracoronary stenting (MATTIS).

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FAJH.10451

retrieved

21 January 2018

Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting : the clopidogrel aspirin stent international cooperative study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FAJH.10451

retrieved

21 January 2018

Final report on the aspirin component of the ongoing Physicians' Health Study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FAJH.10451

retrieved

21 January 2018

ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither. The ISIS-2 (Second International Study of Infarct Survival) Collaborative Group

(Q28166614)

Risk of bleeding complications with antiplatelet agents: meta-analysis of 338,191 patients enrolled in 50 randomized controlled trials

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)